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Conclusion: From a large echo database, symptomatic AS was identified in 0.7% of
patients. The majority of them are either surgical candidates or are excluded by the
current PARTNERS criteria. Only 15% of all severe symptomatic AS patients qualified
for TAVR. This information will be important for institutions considering
implementation of TAVR programs to meet minimal recommended volumes.
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Background: Transcatheter aortic valve implantation (TAVI) has emerged as an
alternative treatment for high risk surgical patients with severe symptomatic aortic
stenosis. Transcatheter aortic valves (TAVs) are implanted in a sutureless fashion using
oversizing to achieve appropriate anchoring and reduce paravalvular leak. Optimal
TAV function requires expansion of the valve to its nominal dimensions. However,
incomplete and non-uniform expansion of TAV was observed in the majority of
patients. Under-expanded TAVs are expected to function suboptimally which may
impact long-term durability. Stress analysis of leaflets and stent after TAVI has not
been studied.
Methods: A computer aided design (CAD) model of a balloon-expandable TAV was
developed based on the 23mm Edwards-SAPIEN valve design and used to create a
finite element (FE) model. The 3D model consists of a stent, three pericardial leaflets,
a clamp compression unit and an expandable balloon. Large deformation FE
simulations were conducted to model TAV crimping and balloon-expansion to 17, 21,
and 23mm.
Results: Stress distribution on the stent and leaflets are shown in Figure 1. As post-
inflation diameter increased, von Mises stress on the TAV stent decreased. Maximum
von Mises stresses on the stent after expansion to 17, 21, and 23mm were 365, 346,
and 262 MPa, respectively. Unlike the stent, the leaflet stress increased as the post-
inflation diameter increased.
Figure 1. Von Mises stress distribution on TAV stent (top) and leaflets (bottom) after
balloon-expansion to 17 and 21mm.
Conclusion: A FE model was developed to model crimping and balloon expansion of
TAVI. Stress on stent and leaflets after implantation was dependent on the internal
diameter of the inflated stent. FE modeling can be used to predict post-TAVI stresses
and evaluate whether a specific TAV size and design is optimal for a specific patient.
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Background: Periprocedural valve dislodgment may occur during transcatheter aortic
valve implantation (TAVI). The aim of this study was to determine the incidence,
timing and predictors of periprocedural valve dislodgment with the Medtronic
Corevalve System (MCS).
Methods: Ninety-eight consecutive patients underwent TAVI with the MCS after a
comprehensive baseline assessment including invasive angiography, echocardiography
and Multi-Slice Computed Tomography (MSCT). The invasive monitoring charts and
angiographic studies of all TAVI procedures were reviewed to determine the incidence
and timing of valve dislodgment.
Results: Valve dislodgment occurred in 18 patients. Patients with valve dislodgment
had a larger Aortic Valve Area (0.76 ± 0.25 cm2 vs. 0.61 ± 0.19 cm2, p = 0.007), lower
mean transaortic gradient (37.65 ± 14.62 mmHg vs. 47.11 ± 16.08 mmHg, p = 0.03)
and significantly less aortic root calcification (Agatston score median 1951 AU (IQR
799 – 3103) vs 3289 AU (IQR 2097 – 4481), p = 0.016). A lower aortic root calcium
score (Agatston score < 2359 AU) was the single independent predictor for valve
dislodgment (OR 3.10, 1.09 – 8.84). After valve dislodgment, the valve could be
successfully retrieved and implanted in the proper anatomic location in all cases. Valve
dislodgment was associated with a lower incidence of post-procedural AR ≥ 2 (11.1%
vs 34.6%, p = 0.05). There were no relevant procedural or clinical implications to valve
dislodgment.
Conclusion: The incidence of periprocedural valve dislodgment was 18% in these
series. Less aortic root calcification appeared the single independent predictor.
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Background: Accurate valve positioning during transcatheter aortic-valve
implantation is crucial in order to achieve optimal results. Our objectives were to
evaluate the exact location of the Edwards-SAPIEN valve in different stages of
implantation and to analyze possible operator-independent movement of the valve
during final deployment.
Methods: We used the C-THV system (Paieon Medical), for evaluating Edwards-
SAPIEN procedures from 4 medical centers. Valve position was analyzed in relation
to the native valve annulus (virtual target line) in several stages during the procedure
and defined as the fraction (%) of valve below the target-line, into the left-ventricle
outflow tract, in relation to the total prosthetic valve height.
Results: The study group consisted of 68 patients; age 82.9±8 years. The proportion
of the valve located below the target line was as follows: before aortic contrast
injection, 37.3±16.1%; after injection, 39±13.1%; during rapid pacing, 32.6±13.8%;
after implantation, 16.7±16.3%. The final location of the implanted valve was
significantly higher than in the other stages of the procedure (p<0.0001). In 91.2% of
cases, final valve location was less than 40% below the target-line. Operator-
independent valve movement toward the aorta occurred between the rapid pacing and
final valve location stages (mean 2±1.43 mm upward movement of valve center, range
-1.3 to 4.6). Multivariate analysis revealed that this movement was independent of
valve version (SAPIEN 2.12±1.32 mm vs. SAPIEN-XT1.87±1.55 mm, p=0.49), valve
size (23 mm 2.13±1.21 mm vs. 26 mm 1.83±1.7 mm, p=0.2), or procedural access
(trans-femoral 1.78±1.41 mm vs. trans-apical 2.39±1.43 mm, p=0.11). This upward
movement was asymmetrical, occurring mainly in the lower part of the valve (3.2±1.4
mm vs. 0.75±1.5 mm for upper part, p<0.001), resulting in valve shortening.
Moderate/severe aortic-valve calcification was associated with a higher upward
movement of the lower valve part than mild calcification (3.8±1.4 mm vs. 2.7±1.6 mm,
p=0.017).
Conclusion: During Edwards-SAPIEN implantation, final valve position seems to be
higher (i.e. towards the aorta) than planned by the operators. Apparently, there is an
operator-independent upward movement of the valve during the final stage of
implantation and possibly asymmetric shortening of the valve, especially in highly
calcified valves.
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